Supreme Court blocks Trump administration from ending gender-affirming care for federal prisoners
The Supreme Court refused to let the Bureau of Prisons end hormone therapy for transgender inmates while a lawsuit continues.
Objective Facts
The Supreme Court on October 21, 2026 denied the Trump administration's emergency application to enforce a Federal Bureau of Prisons policy that would end hormone therapy, transition surgeries and social accommodations for transgender inmates, leaving U.S. District Judge Royce Lamberth's injunction in place. The brief order gave no reasoning, and Justices Clarence Thomas and Samuel Alito said they would have granted the stay. The ACLU brought the case for three inmates held in New Jersey, Florida and Minnesota, and it now covers roughly 1,000 people diagnosed with gender dysphoria. The Justice Department said the order is not a final decision on the merits and that it will continue its appeal in the D.C. Circuit, according to Newsweek.
Left-Leaning Perspective
NPR's Jaclyn Diaz described the order as upholding a pause on a policy NPR's headline labeled anti-trans, and gave space to the ACLU's view that the government's reasons look contrived. States Newsroom's Ariana Figueroa led with the continuation of care for about 1,000 inmates and quoted ACLU attorney Li Nowlin-Sohl. Both pieces also laid out the administration's argument that the care raises security and fairness concerns inside prisons.
Right-Leaning Perspective
Fox News Digital's Louis Casiano covered the Justice Department's September 30 filing largely on the government's terms, repeating Solicitor General D. John Sauer's description of the treatments as "medically disputed and unproven sex-rejecting interventions." After the order, RedState's Susie Moore called it "another setback" for the administration and focused on Thomas and Alito breaking from the majority. RedState's editor's note blamed unelected federal judges for obstructing Trump's agenda. A readable Fox News article on the October 21 order itself did not turn up in searches.
Deep Dive
Donald Trump's January 2025 executive order told the Bureau of Prisons to stop spending federal money to conform an inmate's appearance to the opposite sex. The bureau, which the ACLU says has treated gender dysphoria since at least 1992, issued a revised policy in February 2026 that would taper hormones, bar surgeries and end items such as wigs and makeup. Judge Royce Lamberth blocked it in June, a divided D.C. Circuit panel refused to intervene in September, and the Supreme Court declined on October 21 to step in, with only Justices Thomas and Alito noting dissent. Advocates are right that this is a real loss for the administration on transgender policy, a contrast with the court's earlier moves allowing Trump's military service and passport rules. But coverage calling it a victory for trans rights can overstate the order: it says nothing about the merits and rests on an Administrative Procedure Act finding that the BOP did not explain its reversal, which Reuters and the AP both reported. Conservative outlets correctly note that no court has yet decided whether prisons must provide this care. They give less attention to the AP's report that the government offered no evidence of security problems after decades of treatment. The numbers vary by source: the AP cited about 600 inmates on hormones in 2025, while NPR cited the ACLU's figure of about 800. The case now goes back to the D.C. Circuit, where the Justice Department says it will press its appeal, and to Lamberth's court for further proceedings. The government could also rewrite the policy with a fuller record, which would answer the procedural flaw Lamberth identified. Newsweek noted the case could come back to the Supreme Court on a full appeal.